IRIS UniCatt

De Maria Marchiano, Ruggero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.057
EU - Europa 9.448
AS - Asia 5.183
SA - Sud America 522
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 9
Totale 28.287
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.999
PL - Polonia 3.415
CN - Cina 2.133
SE - Svezia 1.849
SG - Singapore 1.563
IT - Italia 1.041
DE - Germania 719
IE - Irlanda 646
BR - Brasile 478
ID - Indonesia 384
FR - Francia 300
GB - Regno Unito 288
RU - Federazione Russa 287
IN - India 283
TR - Turchia 252
VN - Vietnam 247
FI - Finlandia 240
AT - Austria 173
UA - Ucraina 166
HK - Hong Kong 94
NL - Olanda 91
JP - Giappone 46
BE - Belgio 40
CH - Svizzera 34
IR - Iran 25
ES - Italia 24
RO - Romania 22
CA - Canada 21
CZ - Repubblica Ceca 14
KR - Corea 14
AR - Argentina 13
BG - Bulgaria 13
AZ - Azerbaigian 12
PT - Portogallo 12
MX - Messico 11
NO - Norvegia 11
PK - Pakistan 11
SA - Arabia Saudita 11
CI - Costa d'Avorio 10
CO - Colombia 10
EU - Europa 10
PA - Panama 10
UZ - Uzbekistan 10
IQ - Iraq 9
LV - Lettonia 9
AU - Australia 8
BD - Bangladesh 8
GE - Georgia 8
IL - Israele 8
PH - Filippine 8
TW - Taiwan 8
ZA - Sudafrica 8
AE - Emirati Arabi Uniti 7
CR - Costa Rica 7
DZ - Algeria 6
EC - Ecuador 6
KE - Kenya 6
LK - Sri Lanka 6
LT - Lituania 6
LU - Lussemburgo 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
EE - Estonia 5
GR - Grecia 5
MA - Marocco 5
SC - Seychelles 5
TH - Thailandia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CL - Cile 4
EG - Egitto 4
HU - Ungheria 4
JO - Giordania 4
KZ - Kazakistan 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
BZ - Belize 3
DK - Danimarca 3
HR - Croazia 3
LB - Libano 3
MY - Malesia 3
PE - Perù 3
PS - Palestinian Territory 3
VE - Venezuela 3
BO - Bolivia 2
CM - Camerun 2
GA - Gabon 2
IS - Islanda 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NG - Nigeria 2
PY - Paraguay 2
RS - Serbia 2
TN - Tunisia 2
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
KG - Kirghizistan 1
Totale 28.277
Salva come PNG Salva come JPEG
Città #
Warsaw 3.395
Chandler 1.621
Fairfield 1.488
Ashburn 993
Redmond 767
Singapore 753
Wilmington 729
Woodbridge 693
Houston 666
Dublin 646
Seattle 641
Cambridge 507
Nanjing 483
Jakarta 382
Princeton 344
Ann Arbor 335
Hangzhou 310
Boston 288
San Mateo 244
Dong Ket 242
Beijing 215
Dearborn 205
Izmir 203
Jacksonville 200
Helsinki 196
Cattolica 188
Nanchang 180
Moscow 169
Rome 169
Vienna 160
New York 135
Chicago 122
Milan 113
Munich 112
Shenyang 96
Los Angeles 94
Hyderabad 88
Hong Kong 87
London 87
San Diego 84
Tianjin 78
Bremen 75
Norwalk 74
Hebei 72
Redwood City 69
Kunming 68
Frankfurt am Main 67
Düsseldorf 61
Mountain View 60
Jiaxing 53
Marseille 52
Nuremberg 51
Falkenstein 48
Phoenix 45
Guangzhou 44
São Paulo 41
Brussels 40
Changsha 40
Lauterbourg 39
The Dalles 35
Andover 30
Shanghai 30
Boardman 29
Lawrence 28
Chiswick 27
Augusta 24
Jinan 24
Kocaeli 24
Springfield 21
North Bergen 20
Portsmouth 20
Zurich 20
Kish 18
Paris 18
Zhengzhou 18
Casalecchio di Reno 17
Pune 17
Washington 17
Gloucester 16
Edinburgh 15
Lanzhou 15
Changchun 14
Fort Worth 14
Hounslow 14
Rio de Janeiro 14
Forest City 13
Newark 13
Acton 12
Baku 12
Campinas 12
Curitiba 12
Donostia / San Sebastian 11
Falls Church 11
Kraków 11
Sofia 11
Tokyo 11
Turin 11
Abidjan 10
Amsterdam 10
Gunzenhausen 10
Totale 20.216
Salva come PNG Salva come JPEG
Nome #
CHK1-targeted therapy to deplete DNA replication- stressed, p53-deficient, hyperdiploid colorectal cancer stem cells 367
Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer 334
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes 321
Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy 307
Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations 303
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 286
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real- world experience 281
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 272
Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer 269
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer 265
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer 263
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells. 255
Two-Step Co-Immunoprecipitation (TIP) Enables Efficient and Highly Selective Isolation of Native Protein-Complexes. 252
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 251
Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications 249
Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer 245
Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance 243
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies 242
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 242
A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology 241
miR-663 sustains NSCLC by inhibiting mitochondrial outer membrane permeabilization (MOMP) through PUMA/ BBC3 and BTG2 240
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 238
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer 238
Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy 233
Alliance Against Cancer, the network of Italian cancer centers bridging research and care 231
Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer 231
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal 229
Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis 228
Replication stress in colorectal cancer stem cells 228
(1)H NMR detects different metabolic profiles in glioblastoma stem-like cells 226
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer 223
Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study 220
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes with Different Clinical Outcome 219
The Hippo pathway in normal development and cancer 219
Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression 216
Protein drug target activation homogeneity in the face of intra- tumor heterogeneity: implications for precision medicine 214
Analysis of the ATR-Chk1 and ATM- Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression 212
DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy 211
DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy 206
Colorectal cancer: towards new challenges and concepts of preventive healthcare 206
Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer 203
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 197
HMG-CoAR expression in male breast cancer: Relationship with hormone receptors, Hippo transducers and survival outcomes 192
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B 191
Gene Expression Analysis of PTEN Positive Glioblastoma Stem Cells Identifies DUB3 and Wee1 Modulation in a Cell Differentiation Model 190
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 173
A BMP7 variant inhibits tumor angiogenesis in vitro and in vivo through direct modulation of endothelial cell biology 171
DNA damage and repair biomarkers in cervical cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis 171
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 168
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go 160
Antisense RNA for Treating Cancer and Inhibition of Metastasis and Vectors for Antisense Sequestration 157
A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer 154
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant 150
1H NMR spectroscopy of glioblastoma stem‐like cells identifies alpha‐aminoadipate as a marker of tumor aggressiveness 146
The autophagic protein FYCO1 controls TNFRSF10/TRAIL receptor induced apoptosis and is inactivated by CASP8 (caspase 8) 144
Inhibitor of integrin for the treatment or prevention of tumours 142
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 133
“Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome 129
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 118
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells 118
Alliance Against Cancer, the network of Italian cancer centers bridging research and care 115
C-Met/MIR-130b axis as novel mechanism and biomarker for castration resistance state acquisition 115
A real-time integrated framework to support clinical decision making for covid-19 patients 114
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome 111
C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition 110
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis. 106
Integrin a7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 105
Essential versus accessory aspects of cell death: Recommendations of the NCCD 2015 104
C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition 103
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo 100
Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression 100
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin 100
Two-Step Coimmunoprecipitation (TIP) enables efficient and highly selective isolation of native protein complexes 96
The targeting of mre11 or rad51 sensitizes colorectal cancer stem cells to chk1 inhibition 96
Antitumor effect of miR-197 targeting in p53 wild-type lung cancer 95
Pluripotency and differentiation in embryos and stem cells 95
Two-Step Co-Immunoprecipitation (TIP) 95
Epithelial-mesenchymal transition: a new target in anticancer drug discovery 92
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 91
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 89
Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51 89
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo 87
Nobiletin and xanthohumol sensitize colorectal cancer stem cells to standard chemotherapy 87
Differentiation affects the release of exosomes from colon cancer cells and their ability to modulate the behavior of recipient cells 86
Gene expression analysis of PTEN positive glioblastoma stem cells identifies DUB3 and Wee1 modulation in a cell differentiation model 86
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells 86
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome 85
"Triple positive" early breast cancer: An observational multicenter retrospective analysis of outcome 84
Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer 84
BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition 83
Blocking the APRIL circuit enhances acute myeloid leukemia cell chemosensitivity 83
A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells 83
1H NMR spectroscopy of glioblastoma stem-like cells identifies alpha-aminoadipate as a marker of tumor aggressiveness 82
Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer 82
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 81
The inhibition of the highly expressed mir-221 and mir-222 impairs the growth of prostate carcinoma xenografts in mice 79
1H NMR detects different metabolic profiles in glioblastoma stem-like cells 79
Exploiting bioactive natural products of marine origin: Evaluation of the meroterpenoid metachromin V as a novel potential therapeutic drug for colorectal cancer 79
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo 78
EGFR Inhibition Abrogates Leiomyosarcoma Cell Chemoresistance through Inactivation of Survival Pathways and Impairment of CSC Potential 78
Totale 16.856
Salva come PNG Salva come JPEG
Categoria #
all - tutte 142.192
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.192
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020734 0 0 0 0 0 0 0 0 0 0 567 167
2020/20212.991 257 323 199 149 406 195 477 73 238 217 170 287
2021/20222.787 260 264 126 131 162 145 72 414 132 124 472 485
2022/20235.117 756 695 466 547 372 642 111 447 668 125 200 88
2023/20242.725 101 911 86 132 115 216 200 83 31 84 342 424
2024/20254.231 225 120 482 228 365 345 224 401 962 758 121 0
Totale 28.818